Loading
This page follows insider dealings at Stem Cells Spin SA as filed with KNF. The last twelve months, up to 24 October 2026, brought 2 filings signed by 1 insider.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
There has been no open-market purchase by an insider of Stem Cells Spin SA for at least a year.
For context, the typical company on the same exchange (median of 554 companies) published 3 filings over the same period, against 2 filings here.
This summary is built from KNF disclosures alone and does not predict where the share price will go.
· cache
2 of 2 declarations
Stem Cells Spin SA is a company focused on the research and development of stem cell-based therapies. It is listed on the XWAR market.